Detalhe da pesquisa
1.
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.
Oncologist
; 29(2): 159-165, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669224
2.
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.
Oncologist
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716772
3.
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Oncologist
; 29(1): 75-83, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548439
4.
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Mod Pathol
; 37(2): 100375, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925055
5.
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability.
Oncologist
; 28(11): 944-960, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665782
6.
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer.
Curr Opin Oncol
; 35(6): 479-490, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621170
7.
TERT promoter mutations and gene amplification in endometrial cancer.
Gynecol Oncol
; 179: 16-23, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890416
8.
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma.
Gynecol Oncol
; 174: 262-272, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37245486
9.
Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer.
Cancer Treat Res
; 188: 219-235, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175348
10.
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?
Breast Cancer Res Treat
; 192(3): 465-484, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124720
11.
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.
Mod Pathol
; 35(7): 962-971, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972830
12.
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Mod Pathol
; 35(2): 193-201, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599282
13.
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
Int J Gynecol Cancer
; 32(8): 1017-1024, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545291
14.
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials.
Oncologist
; 25(11): e1732-e1742, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785940
15.
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden.
Oncologist
; 25(9): 803-809, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369650
16.
Recent advances in triple negative breast cancer: the immunotherapy era.
BMC Med
; 17(1): 90, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068190
17.
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.
Nat Rev Clin Oncol
; 21(3): 185-202, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191924
18.
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer.
Cancer Treat Rev
; 128: 102761, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772169
19.
PARP Inhibitors for Breast Cancer Treatment: A Review.
JAMA Oncol
; 10(5): 658-670, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512229
20.
Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation.
J Clin Invest
; 134(1)2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883178